2006 Annual Meeting | From Bench to Bedside: Update on Neuromuscular Disease

��ɫ��

2006 Annual Meeting | From Bench to Bedside: Update on Neuromuscular Disease

Date Saturday 04/01/06

Time 06:00 PM - 08:00 PM Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Kick-Off Program

Director(s) Christopher J. Klein, MD, FAAN

Topic(s)

Learning Objectives Upon Completion:
Participants should become familiar with the current molecular understanding of neuromuscular diseases with application in the differential diagnoses, workup including genetic testing, and treatment of common and uncommon nerve, muscle, and neuromuscular junction diseases.

CME Available No CME available

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Advanced

Recommended Audience Practitioner, Fellow, Academician, Resident

Event Timeline
06:00 PM - 06:40 PM		Application of the New Biology in Peripheral Neuropathy Christopher J. Klein, MD, FAAN
06:00 PM - 08:00 PM		Reception
06:40 PM - 07:15 PM		Molecular Basis and Therapy of Muscle Disease Michael Sinnreich, MD, PhD
07:15 PM - 08:00 PM		Neuromuscular Junction Andrew G. Engel, MD, FAAN

Faculty Disclosures
Andrew G. Engel, MD, FAAN	The institution of Dr. Engel has received research support from NIH.
Christopher J. Klein, MD, FAAN	Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda. Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Sangamo Therapeutics . Dr. Klein has received personal compensation in the range of $500-$4,999 for serving as a Consultant for NMD Pharma.
Michael Sinnreich, MD, PhD	Prof. Sinnreich has nothing to disclose.

��ɫ����

��ɫ����

��ɫ��

��ɫ��